The ReSound OMNIA RIE is a premium-priced prescription hearing aid released in 2022, earning a B grade with a SoundScore of 3.78 out of 5 in HearAdvisor's lab testing. As a behind-the-ear receiver-in-ear device priced at $4,764, it sits in the highest price tier but ranks in the bottom 35% of prescription hearing aids tested.
In our lab testing, the OMNIA RIE demonstrated notable strength in speech intelligibility in quiet environments, scoring 0.69 points above the category average. Own-voice comfort also measured slightly above average, suggesting reasonable occlusion management with its closed dome coupling. However, the device showed meaningful weaknesses in speech-in-noise performance, measuring 0.52 points below average—a critical consideration since challenging listening environments are often the primary reason people seek hearing aids.
Music streaming quality and feedback handling both fell below category averages in our testing, with feedback scores 0.67 points under the norm. At this premium price point, several competitors deliver stronger overall performance, including the Oticon Intent (4.70/5) and Phonak Sphere Infinio (4.64/5). For budget-conscious consumers, devices like the Lucid Tala at $1,300 achieved a higher SoundScore of 4.64.
The ReSound OMNIA RIE may appeal to users who prioritize speech clarity in quieter settings and value ReSound's ecosystem features, including iPhone and Android streaming with hands-free capability. However, those frequently navigating noisy environments or seeking top-tier sound performance at this price point should consider alternatives that scored higher in our comprehensive testing.
